Artal Group S.A. - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 67 filers reported holding NOVELION THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$315,000
+46.5%
256,4000.0%0.01%
+62.5%
Q4 2018$215,000
-71.7%
256,4000.0%0.01%
-60.0%
Q3 2018$759,000
-19.6%
256,4000.0%0.02%0.0%
Q2 2018$944,000
+5.2%
256,4000.0%0.02%
+81.8%
Q1 2018$897,000
+12.1%
256,4000.0%0.01%
-8.3%
Q4 2017$800,000
-55.6%
256,4000.0%0.01%
-61.3%
Q3 2017$1,802,000
-23.9%
256,4000.0%0.03%
-24.4%
Q2 2017$2,367,000
-14.1%
256,4000.0%0.04%
-32.8%
Q1 2017$2,754,000
+27.6%
256,4000.0%0.06%
+27.1%
Q4 2016$2,159,000256,4000.05%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 1,800,000$1,404,0002.63%
Stonepine Capital Management, LLC 491,096$383,0000.26%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 918,342$716,0000.05%
KNOTT DAVID M 109,135$85,0000.04%
EdgePoint Investment Group Inc. 2,831,555$2,209,0000.02%
Yakira Capital Management, Inc. 36,428$28,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$36,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 85,409$66,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 37,717$29,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders